Insider Buying and Selling - BLTE

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
04/23/2026 10b5-1	04/24/2026	Mata Nathan L. Chief Scientific Officer Officer	Sell	-1,000 @ $166.28	($166,283.76)	9,666	(-9.38%)	Direct
04/22/2026 10b5-1	04/23/2026	Mata Nathan L. Chief Scientific Officer Officer	Sell	-1,000 @ $170.38	($170,384.30)	10,666	(-8.57%)	Direct
04/21/2026 10b5-1	04/22/2026	Mata Nathan L. Chief Scientific Officer Officer	Sell	-1,000 @ $166.00	($166,000.39)	11,666	(-7.90%)	Direct
04/20/2026 10b5-1	04/21/2026	Mata Nathan L. Chief Scientific Officer Officer	Sell	-1,000 @ $163.59	($163,594.55)	12,666	(-7.32%)	Direct
04/17/2026 10b5-1	04/20/2026	Mata Nathan L. Chief Scientific Officer Officer	Sell	-1,000 @ $161.63	($161,629.79)	13,666	(-6.82%)	Direct
04/16/2026 10b5-1	04/20/2026	Mata Nathan L. Chief Scientific Officer Officer	Sell	-1,000 @ $160.38	($160,380.53)	14,666	(-6.38%)	Direct
04/15/2026 10b5-1	04/16/2026	Mata Nathan L. Chief Scientific Officer Officer	Sell	-1,000 @ $168.30	($168,298.12)	15,666	(-6.00%)	Direct
04/09/2026 10b5-1	04/13/2026	Chen Wan-Shan Director	Sell	-1,100 @ $180.43	($198,473.11)	9,096	(-10.79%)	Direct
04/09/2026 10b5-1	04/13/2026	Chuang Hao-Yuan Chief Financial Officer CFO Director	Sell	-6,200 @ $181.50	($1,125,303.44)	93,800	(-6.20%)	Direct
04/09/2026 10b5-1	04/13/2026	Lin Yu-Hsin Chief Executive Officer CEO Director	Sell	-9,200 @ $181.45	($1,669,338.90)	170,934	(-5.11%)	Direct

BELITE BIO, INC - BLTE